Search - tctmd.com

Displaying 21 - 40 of 432

Sort: Relevancy | Date

Presentation TCT 2025

TCT 579: Long-term Efficacy of Renal Denervation in Patients with Resistant Arterial Hypertension: 5-year Results

Presenter: Alla Falkovskaya

October 27, 2025

Presentation TCT 2025

Case 3: My Patient is on 6 Anti-Hypertensives - Are They Taking Them? and Is Renal Denervation Futile?

Presenter: David E. Kandzari

October 27, 2025

Presentation TCT 2025

TCT 576: Pain Mitigation in Pancreatic Adenocarcinoma: An Analysis of Denervation via Transvascular RF Energy-Based Ablation

Presenter: Robert S. Schwartz

October 27, 2025

Presentation TCT 2025

Case 2: My Patient Has Abnormal Renal Arteries - Can I Still Do Renal Denervation?

Presenter: Lucas Lauder

October 27, 2025

Presentation TCT 2025

TCT 574: Efficacy of Ultrasound Renal Denervation Based Upon Changes in Detected Antihypertensive Medications Within the RADIANCE-HTN TRIO study

Presenter: Joost Daemen

October 27, 2025

Presentation TCT 2025

TCT 569: Potential of Novel Metrics for Long-Term Assessment of Renal Denervation Efficacy in Patients with Resistant Hypertension

Presenter: Alla Falkovskaya

October 27, 2025

Presentation TCT 2025

Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

Presenter: Vivek Y. Reddy

October 27, 2025

Presentation TCT 2025

TCT 573: The Impact of Hypertension on the Burden of Ischemic Heart Disease in the United States: Temporal Analysis of the Past 3 Decades

Presenter: Zaid Ali Abdulelah

October 27, 2025

Presentation TCT 2025

Efficacy and Safety of Ultrasound-Based Renal Denervation in Patients with Autosomal Dominant Polycystic Kidney Disease: Results from the RDN-ADPKD study

Presenter: Roland E. Schmieder

October 27, 2025

Presentation TCT 2025

Update on Mapping Technology for Renal Denervation with 12M results of SMART study (SyMap Medical)

Presenter: Jie Wang

October 27, 2025

Presentation TCT 2025

THRIVE Trial in Focus: What the Upcoming Evidence Could Mean

Presenter: Felix Mahfoud

October 26, 2025

Presentation TCT 2025

TIVUS: Ultrasound-Based Intervention in Early Practice

Presenter: Michael Jonas

October 26, 2025

Presentation TCT 2025

Mapping the Evidence: A Review of the Renal Denervation Clinical Trial Landscape

Presenter: Eric A. Secemsky

October 26, 2025

Presentation TCT 2025

Hypertension Today: Understanding the Burden & the Numbers that Matter

Presenter: Naomi D.L. Fisher

October 26, 2025

Presentation TCT 2025

Scaling Renal Denervation: Lessons from Early Adopters on Program Growth and Sustainability

Presenter: Matheen A. Khuddus

October 26, 2025

Presentation TCT 2025

Reimbursement Roadmap: Coding, Coverage, and Payment for Renal Denervation

Presenter: Vijay Iyer

October 26, 2025

Presentation TCT 2025

RDN Practice Development: Integrating Evidence, Workflow, and Economics

Presenter: Chandan Devireddy

October 26, 2025

Presentation TCT 2025

Building a Successful Renal Denervation Program: From Patient Selection to Long-Term Follow-Up

Presenter: Michael Bloch

October 26, 2025

Presentation TCT 2025

Durable Safety and Efficacy of Renal Denervation using the Symplicity Spyral Catheter in Patients Taking Antihypertensive Drugs: Final, 3-Year Results from the SPYRAL HTN-ON MED Randomized Study

Presenter: David E. Kandzari

October 26, 2025

Presentation TCT 2025

How to Perform a Renal Denervation Procedure?

Presenter: Andrew Sharp

October 26, 2025

Advertisement

TCT 579: Long-term Efficacy of Renal Denervation in Patients with Resistant Arterial Hypertension: 5-year Results

Case 3: My Patient is on 6 Anti-Hypertensives - Are They Taking Them? and Is Renal Denervation Futile?

TCT 576: Pain Mitigation in Pancreatic Adenocarcinoma: An Analysis of Denervation via Transvascular RF Energy-Based Ablation

Case 2: My Patient Has Abnormal Renal Arteries - Can I Still Do Renal Denervation?

TCT 574: Efficacy of Ultrasound Renal Denervation Based Upon Changes in Detected Antihypertensive Medications Within the RADIANCE-HTN TRIO study

TCT 569: Potential of Novel Metrics for Long-Term Assessment of Renal Denervation Efficacy in Patients with Resistant Hypertension

Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

TCT 573: The Impact of Hypertension on the Burden of Ischemic Heart Disease in the United States: Temporal Analysis of the Past 3 Decades

Efficacy and Safety of Ultrasound-Based Renal Denervation in Patients with Autosomal Dominant Polycystic Kidney Disease: Results from the RDN-ADPKD study

Update on Mapping Technology for Renal Denervation with 12M results of SMART study (SyMap Medical)

THRIVE Trial in Focus: What the Upcoming Evidence Could Mean

TIVUS: Ultrasound-Based Intervention in Early Practice

Mapping the Evidence: A Review of the Renal Denervation Clinical Trial Landscape

Hypertension Today: Understanding the Burden & the Numbers that Matter

Scaling Renal Denervation: Lessons from Early Adopters on Program Growth and Sustainability

Reimbursement Roadmap: Coding, Coverage, and Payment for Renal Denervation

RDN Practice Development: Integrating Evidence, Workflow, and Economics

Building a Successful Renal Denervation Program: From Patient Selection to Long-Term Follow-Up

Durable Safety and Efficacy of Renal Denervation using the Symplicity Spyral Catheter in Patients Taking Antihypertensive Drugs: Final, 3-Year Results from the SPYRAL HTN-ON MED Randomized Study

How to Perform a Renal Denervation Procedure?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content